Therapeutic mesenchymal stem/stromal cells: value, challenges and optimization

M Najar, R Melki, F Khalife, L Lagneaux… - Frontiers in cell and …, 2022 - frontiersin.org
Cellular therapy aims to replace damaged resident cells by restoring cellular and molecular
environments suitable for tissue repair and regeneration. Among several candidates …

[HTML][HTML] Age-related changes in the inflammatory status of human mesenchymal stem cells: implications for cell therapy

Y Zhang, M Ravikumar, L Ling, V Nurcombe, SM Cool - Stem cell reports, 2021 - cell.com
Human mesenchymal stem/stromal cell (hMSC)-based cell therapies are promising for
treating a variety of diseases. The unique immunomodulatory properties of hMSCs have …

Mesenchymal stromal cells as a driver of inflammaging

S Lyamina, D Baranovskii, E Kozhevnikova… - International Journal of …, 2023 - mdpi.com
Life expectancy and age-related diseases burden increased significantly over the past few
decades. Age-related conditions are commonly discussed in a very limited paradigm of …

Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies

X Yang, Y Wang, V Rovella, E Candi, W Jia… - Biology Direct, 2023 - Springer
Natural ageing of organisms and corresponding age-related diseases result mainly from
stem cell ageing and “inflammaging”. Mesenchymal stem cells (MSCs) exhibit very high …

The use of pulsed electromagnetic field to modulate inflammation and improve tissue regeneration: a review

CL Ross, Y Zhou, CE McCall, S Soker, TL Criswell - Bioelectricity, 2019 - liebertpub.com
Pulsed electromagnetic field (PEMF) is emerging as innovative treatment for regulation of
inflammation, which could have significant effects on tissue regeneration. PEMF modulates …

Unique characteristics of human mesenchymal stromal/progenitor cells pre-activated in 3-dimensional cultures under different conditions

JH Ylostalo, TJ Bartosh, A Tiblow, DJ Prockop - Cytotherapy, 2014 - Elsevier
Background aims Human mesenchymal stromal cells (MSCs) are being used in clinical
trials, but the best protocol to prepare the cells for administration to patients remains unclear …

The current 'state of play'of regenerative medicine in horses: what the horse can tell the human

RKW Smith, ER Garvican, LA Fortier - Regenerative Medicine, 2014 - Taylor & Francis
The horse is an attractive model for many human age-related degenerative diseases of the
musculoskeletal system because it is a large animal species that both ages and exercises …

Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome

C Liu, K Xiao, L Xie - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) develops rapidly and
has high mortality. ALI/ARDS is mainly manifested as acute or progressive hypoxic …

Low level laser (LLL) attenuate LPS-induced inflammatory responses in mesenchymal stem cells via the suppression of NF-κB signaling pathway in vitro

K Yin, R Zhu, S Wang, RC Zhao - PLoS One, 2017 - journals.plos.org
Background Considering promising results in animal models and patients, therapeutic use
of MSCs for immune disease is likely to undergo continued evaluation. Low-lever laser (LLL) …

Smoking impairs the immunomodulatory capacity of lung-resident mesenchymal stem cells in chronic obstructive pulmonary disease

T Cruz, A Lopez-Giraldo, G Noell, A Guirao… - American journal of …, 2019 - atsjournals.org
Tobacco smoking is the main environmental risk factor for chronic obstructive pulmonary
disease (COPD), but not all smokers develop the disease. A population of lung-resident …